NU62PS924842
Cooperative Agreement
Overview
Grant Description
High impact HIV prevention and surveillance programs for health departments - project abstract summary
In West Virginia, there were 136 individuals newly diagnosed with HIV in 2020.
Although the rate of new HIV diagnoses decreased nationally between 2018 and 2020 (13.6 to 10.9), the rate in West Virginia increased significantly during that same time from 5.6 in 2018 to 9.1 in 2020.
The number of people diagnosed with HIV in West Virginia increased overall between 2016-2020 by 103%, and nearly tripled for females (292%).
West Virginia is currently responding to four outbreaks/clusters throughout the state, three associated with injection drug use and one in the men who have sex with men population.
The purpose of this application is to obtain funding for the Division of STD, HIV, Hepatitis, and Tuberculosis (DSHHT) of the West Virginia Department of Health to provide a comprehensive high impact HIV prevention and surveillance program.
The strategies proposed will increase individual knowledge of HIV status, prevent new HIV infections, reduce transmission from persons living with HIV, improve health outcomes for persons living with HIV infection, eliminate perinatal transmission, strengthen surveillance to enhance response capacity, and employ data-to-care activities to support sustained viral suppression.
Strategies will be implemented by using quality, timely, and complete surveillance and program data to guide HIV prevention and response efforts.
The DSHHT will continue to expand partnerships with healthcare providers, local health departments, and community-based organizations in order to reach the national HIV/AIDS strategy goals of preventing new HIV infections, improving HIV-related health outcomes for people with HIV, reducing HIV-related disparities and health inequities, and achieving integrated efforts that address the HIV epidemic.
In West Virginia, there were 136 individuals newly diagnosed with HIV in 2020.
Although the rate of new HIV diagnoses decreased nationally between 2018 and 2020 (13.6 to 10.9), the rate in West Virginia increased significantly during that same time from 5.6 in 2018 to 9.1 in 2020.
The number of people diagnosed with HIV in West Virginia increased overall between 2016-2020 by 103%, and nearly tripled for females (292%).
West Virginia is currently responding to four outbreaks/clusters throughout the state, three associated with injection drug use and one in the men who have sex with men population.
The purpose of this application is to obtain funding for the Division of STD, HIV, Hepatitis, and Tuberculosis (DSHHT) of the West Virginia Department of Health to provide a comprehensive high impact HIV prevention and surveillance program.
The strategies proposed will increase individual knowledge of HIV status, prevent new HIV infections, reduce transmission from persons living with HIV, improve health outcomes for persons living with HIV infection, eliminate perinatal transmission, strengthen surveillance to enhance response capacity, and employ data-to-care activities to support sustained viral suppression.
Strategies will be implemented by using quality, timely, and complete surveillance and program data to guide HIV prevention and response efforts.
The DSHHT will continue to expand partnerships with healthcare providers, local health departments, and community-based organizations in order to reach the national HIV/AIDS strategy goals of preventing new HIV infections, improving HIV-related health outcomes for people with HIV, reducing HIV-related disparities and health inequities, and achieving integrated efforts that address the HIV epidemic.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
West Virginia
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 256% from $1,066,800 to $3,797,310.
West Virginia State Health Department was awarded
High Impact HIV Prevention Program for West Virginia Health Department
Cooperative Agreement NU62PS924842
worth $3,797,310
from National Center for HIV, Viral Hepatitis, STD, and TB Prevention in August 2024 with work to be completed primarily in West Virginia United States.
The grant
has a duration of 4 years 9 months and
was awarded through assistance program 93.939 HIV Prevention Activities Non-Governmental Organization Based.
The Cooperative Agreement was awarded through grant opportunity High-Impact HIV Prevention and Surveillance Programs for Health Departments.
Status
(Ongoing)
Last Modified 6/22/26
Period of Performance
8/1/24
Start Date
5/31/29
End Date
Funding Split
$3.8M
Federal Obligation
$0.0
Non-Federal Obligation
$3.8M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for NU62PS924842
Transaction History
Modifications to NU62PS924842
Additional Detail
Award ID FAIN
NU62PS924842
SAI Number
NU62PS924842-668887455
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CVJ0 CDC NATIONAL CENTER FOR HIV/AIDS, VIRAL HEPATITIS, STD, AND TUBERCULOSIS PREVENTION
Awardee UEI
UB8BRMRKAHY3
Awardee CAGE
9RNM1
Performance District
WV-90
Senators
Joe Manchin
Shelley Capito
Shelley Capito
Modified: 6/22/26